Advanced Biomed Inc. SEC filings ADVB
Advanced Biomed Inc. has 98 filings in SEC EDGAR's recent list, going back to Nov 30, 2022. Its latest annual report, Form 10-K, was filed on Oct 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Jul 17, 2026 (agreement ended). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 22, 2026 | — |
| 4 | Insider transaction | Aug 20, 2026 | Jul 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 20, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 20, 2026 | — |
Showing 4 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- ADVB (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Reno, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1941029
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.